LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Clinical trial NCT01298934 · UNKNOWN

Trial details

NCT number: NCT01298934
Sponsor: Ronald Hoffman
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Post-Essential Thrombocythemia Related Myelofibrosis

Start date: 2009-09-01
Primary completion: 2015-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.